Monday, June 6, 2022

Retinal Biologics Market Is Set to Expand at a CAGR Of 11.1% To reach US$ 41.92 Billion ...

... as a promising drug target; Development of gene therapy as retinal biologics in the wake of large number of monogenic retinal disorders.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...